Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 11, 2022

SELL
$347.28 - $421.83 $34.6 Million - $42 Million
-99,615 Closed
0 $0
Q3 2021

Nov 09, 2021

SELL
$405.61 - $524.84 $4.62 Million - $5.97 Million
-11,382 Reduced 10.25%
99,615 $40.4 Million
Q2 2021

Aug 11, 2021

BUY
$372.84 - $481.5 $41.4 Million - $53.4 Million
110,997 New
110,997 $52.5 Million
Q3 2020

Nov 12, 2020

SELL
$268.51 - $400.74 $13.4 Million - $20 Million
-50,000 Closed
0 $0
Q2 2020

Aug 14, 2020

BUY
$256.46 - $373.01 $12.8 Million - $18.7 Million
50,000 New
50,000 $18.5 Million
Q1 2020

May 14, 2020

SELL
$209.2 - $335.53 $3.02 Million - $4.85 Million
-14,446 Closed
0 $0
Q4 2019

Feb 14, 2020

BUY
$288.29 - $335.49 $15,567 - $18,116
54 Added 0.38%
14,446 $4.79 Million
Q3 2019

Nov 14, 2019

BUY
$266.84 - $378.23 $30,152 - $42,739
113 Added 0.79%
14,392 $4.38 Million
Q2 2019

Aug 14, 2019

SELL
$300.59 - $368.15 $18.6 Million - $22.8 Million
-61,819 Reduced 81.24%
14,279 $5.26 Million
Q1 2019

May 15, 2019

SELL
$272.57 - $321.18 $46.6 Million - $54.9 Million
-170,794 Reduced 69.18%
76,098 $23.6 Million
Q4 2018

Feb 14, 2019

SELL
$272.46 - $366.54 $32.7 Million - $44.1 Million
-120,192 Reduced 32.74%
246,892 $74.1 Million
Q3 2018

Nov 14, 2018

SELL
$279.04 - $367.06 $11.6 Million - $15.2 Million
-41,505 Reduced 10.16%
367,084 $135 Million
Q2 2018

Aug 14, 2018

BUY
$228.17 - $292.07 $8.92 Million - $11.4 Million
39,095 Added 10.58%
408,589 $114 Million
Q1 2018

May 15, 2018

BUY
$209.54 - $253.91 $29.5 Million - $35.8 Million
140,973 Added 61.69%
369,494 $87.4 Million
Q4 2017

Feb 14, 2018

BUY
$202.23 - $230.03 $11.2 Million - $12.7 Million
55,193 Added 31.84%
228,521 $49.9 Million
Q3 2017

Nov 14, 2017

BUY
$172.3 - $213.93 $14.7 Million - $18.3 Million
85,402 Added 97.13%
173,328 $34.5 Million
Q2 2017

Aug 14, 2017

BUY
N/A
87,926
87,926 $15.3 Million

Others Institutions Holding ILMN

About ILLUMINA, INC.


  • Ticker ILMN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 157,300,000
  • Market Cap $21.9B
  • Description
  • Illumina, Inc. provides sequencing and array-based solutions for genetic and genomic analysis. Its products and services serve customers in a range of markets enabling the adoption of genomic solutions in research and clinical settings for applications in the life sciences, oncology, reproductive health, agriculture, and other emerging segments....
More about ILMN
Track This Portfolio

Track Lord, Abbett & Co. LLC Portfolio

Follow Lord, Abbett & Co. LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Lord, Abbett & Co. LLC, based on Form 13F filings with the SEC.

News

Stay updated on Lord, Abbett & Co. LLC with notifications on news.